News

The Delhi High Court on Tuesday disposed of a public interest litigation (PIL) raising alarm over the off-label and ...
Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...
IcoSema, a combination therapy of basal insulin icodec and semaglutide, achieves a noninferior reduction in A1c levels compared with basal-bolus therapy in adults with T2D.
The World Economic Forum, in collaboration with Dubai Future Foundation, has released its Top 10 Emerging Technologies of 2025 report, which spotlights scientific and technological breakthroughs ...
Treating cancer patients who have type II diabetes is a challenge, especially as cardiac, renal, and neurologic complications need to be considered. This review discusses the evidence from ...
Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...
This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.
Discover how a 5-day fasting-mimicking diet revolutionizes type 2 diabetes management, reducing medications and improving ...
Medicaid insures one in four Pennsylvania residents, and it is poised for cuts under President Donald Trump’s first major ...
While severe maternal hypothyroidism (low thyroid hormone levels) in pregnancy is known to increase risks of adverse ...
CGM use vs self-monitoring was not associated with improved obstetric or neonatal outcomes among women with gestational diabetes.
GLP-1RA use initially lowered delirium risk but eventually heightened delirium risk after 5 years among patients with type 2 diabetes.